John S McGrath
Overview
Explore the profile of John S McGrath including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
868
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khadhouri S, Gallagher K, MacKenzie K, Shah T, Gao C, Zimmermann E, et al.
BJUI Compass
. 2025 Jan;
6(1):e475.
PMID: 39877557
Objectives: To assess the contemporary malignancy rate in isolated de novo red patches in the bladder and associated risk factors for better selection of red patch biopsy. Patients: Patients from...
2.
Abdelqader B, McGrath A, Kotecha P, McGrath J, John J
BJU Int
. 2025 Jan;
PMID: 39873242
No abstract available.
3.
Alexander C, Nathan A, Light A, Gao C, Chan V, Khadhouri S, et al.
BJUI Compass
. 2024 Nov;
5(11):1044-1051.
PMID: 39539562
Objective: The objective of this study was to report the 12-month oncological outcomes for patients with non-muscle-invasive bladder cancer (NMIBC) within the prospective, international COVIDSurg Cancer study. Patients And Methods:...
4.
John J, Gray W, Briggs T, McGrath J
Nat Rev Urol
. 2024 Sep;
PMID: 39333389
An urgent need for societal transformation exists to reduce the environmental impact of humanity, because environmental health affects human health. Health care causes ~5% of global greenhouse gas emissions and...
5.
John J, Collins M, Eames S, OFlynn K, Briggs T, Gray W, et al.
BJU Int
. 2024 Jul;
135(1):78-87.
PMID: 39051536
Objectives: To evaluate the carbon footprint of the perioperative transurethral resection of bladder tumour (TURBT) pathway from decision to treat to postoperative discharge, and model potential greenhouse gas (GHG) emissions...
6.
John J, Gray W, OFlynn K, Briggs T, McGrath J
BJU Int
. 2024 Apr;
134(2):141-147.
PMID: 38637952
The Getting It Right First Time (GIRFT) programme is a quality improvement initiative covering the National Health Service in England. The programme aims to standardise clinical practices and improve patient...
7.
Merriel S, Archer S, Forster A, Eldred-Evans D, McGrath J, Ahmed H, et al.
Br J Gen Pract
. 2024 Apr;
74(745):e527-e533.
PMID: 38575181
Background: Magnetic resonance imaging (MRI) of the prostate is a new, more accurate, non-invasive test for prostate cancer diagnosis. Aim: To understand the acceptability of MRI for patients and GPs...
8.
Cantwell C, McGrath J, Smith C, Whyte G
Micromachines (Basel)
. 2024 Jan;
15(1).
PMID: 38258146
Using devices with microfluidic channels can allow for precise control over liquids flowing through them. Merging flows of immiscible liquids can create emulsions with highly monodispersed microdroplets within a carrier...
9.
Mou Z, Spencer J, McGrath J, Harries L
Hum Genomics
. 2023 Nov;
17(1):97.
PMID: 37924098
Background: Alternative splicing (AS) plays a crucial role in transcriptomic diversity and is a hallmark of cancer that profoundly influences the development and progression of prostate cancer (PCa), a prevalent...
10.
Ho M, Black A, Zargar H, Fairey A, Mertens L, Dinney C, et al.
Can Urol Assoc J
. 2023 Oct;
17(10):301-309.
PMID: 37851909
Introduction: Cisplatin-based neoadjuvant chemotherapy (NAC) is the standard of care for patients with muscle-invasive bladder cancer (MIBC) undergoing radical cystectomy (RC). Cisplatin, however, can induce renal toxicity. Furthermore, RC is...